Global medical aesthetics company Classys announced on the 10th that it is building a system that enables the stable production of high-quality products and their timely supply to global markets through system innovation across its research and development (R&D) and manufacturing headquarters.


Classys is explaining the company's competitiveness at IMCAS 2026. Classys

Classys is explaining the company's competitiveness at IMCAS 2026. Classys

View original image

Classys believes that, given the characteristics of its energy-based aesthetic medical devices, such as the focused ultrasound (HIFU) Shurink and the monopolar RF (MRF) Volnewmer, the precision of energy delivery and consistency of quality are of paramount importance. To support this, the company has continuously invested in advancing its technologies and modernizing its manufacturing systems.


Classys is currently researching and advancing next-generation artificial intelligence (AI) control technologies for its key devices to enhance the stability and reproducibility of energy delivery. This is a technological approach aimed at managing various factors more precisely, including tissue response, temperature changes, and output stability, with the goal of making the entire energy delivery process more uniform and predictable.


In the manufacturing sector, Classys is also gradually establishing factory automation and smart factory infrastructure, thereby simultaneously improving productivity and quality control standards. Through process standardization, the introduction of automated equipment, and the advancement of its quality management system, the company has minimized quality variations between products and built a production structure capable of responding stably to growing global demand. Through these production innovations, Classys has secured the capability to supply high-quality products to its global partners according to planned schedules.


The research and development and manufacturing capabilities of Classys received positive evaluations from global partners and leading medical experts at the International Master Course on Aging Science (IMCAS 2026), held recently in Paris, France.



A Classys representative said, "In the medical aesthetics market, it is extremely important not only that the devices perform well, but also that there is trust that products will always be supplied with consistent quality and in a stable manner," adding, "Classys is continuously strengthening the foundation that global partners and customers can rely on through system innovation that encompasses the entire spectrum of research and development and manufacturing."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing